Table 1.

Descriptive characteristics of patient populations in S8897 trial and Pathways Study

Characteristic	S8897 T reated Group	S8897 Untreated Group	Pathways Chemotherapy Group	Pathways No Chemotherapy Group
	n = 441 (%)	n = 799 (%)	n = 515 (%)	n = 483 (%)
Age, years
< 40	66 (15)	70 (9)	93 (19)	21 (4)
40-49	165 (37)	225 (28)	211 (44)	125 (26)
50-59	105 (24)	211 (26)	118 (24)	127 (26)
60-69	76 (17)	199 (25)	74 (15)	121 (25)
≥ 70	29 (7)	94 (12)	19 (4)	89 (18)
Median(Range), years	49 (27-85)	54 (24-89)	47 (25-76)	56 (23-89)
Race
White (non-Hispanic)	391 (89)	750 (93)	270 (52)	298 (62)
Black (non-Hispanic)	27 (6)	30 (4)	37 (7)	37 (8)
Hispanic	12 (3)	12 (2)	93 (18)	57 (12)
Other	11 (2)	7 (1)	115 (23)	91 (19)
Menopausal Status
Premenopausal	231 (52)	306 (38)	350 (68)	213 (44)
Postmenopausal	210 (48)	493 (62)	165 (32)	270 (56)
Overall Survival Event
Yes	329 (75)	577 (72)	45 (9)	32 (7)
No	112 (25)	222 (28)	470 (91)	451 (93)
Disease Free Survival Event
Yes	289 (66)	482 (60)	80 (16)	71 (15)
No	152 (34)	317 (40)	435 (84)	412 (85)